LABORATORY CORP OF AMERICA HOLDINGS
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Index
Item 9B. OTHER INFORMATION
Insider Adoption or Termination of Trading Arrangements:
During the fiscal quarter ended December 31, 2023, none of the Company's directors or officers informed it of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:
| Name and Title · Date Adopted · Character of Trading Agreement · Aggregate Number of Shares of Common Stock to be (Sold) Purchased Pursuant to Trading Agreement · Duration | ||||||
|---|---|---|---|---|---|---|
| Mark S. Schroeder | 12/7/2023 | Rule 10b5-1 Trading Arrangement | Up to | (17,044) | (1) (2) | 12/6/2024 (3) |
| President, Diagnostics Laboratories andChief Operations Officer | ||||||
| Amy B. Summy | 12/7/2023 | Rule 10b5-1 Trading Arrangement | Up to | (4,916) | (1) (2) | 4/1/2024 (3) |
| Chief Marketing Officer | ||||||
(1)The figure presented represents the shares to be sold on the vesting of equity awards before reduction for shares to be withheld for tax purposes.
(2) Mr. Schroeder’s plan provides for the exercise of vested stock options and the associated sale of up to 2,119 shares of the Company’s Common Stock.
(3)This trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales on the respective order entry date or (b) the date listed in the table.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.